Skip Navigation Genome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteGenome.gov - National Human Genome Research InstituteNational Institutes of Health
   
       Home | About NHGRI | Newsroom | Staff
Research Grants Health Policy & Ethics Educational Resources Careers & Training

Home>Careers & Training>Working at NHGRI>Postdoctoral Positions at NHGRI >Charcot-Marie-Tooth Association (CMTA) Post-Doctoral Fellowship

Charcot-Marie-Tooth Association (CMTA) Post-Doctoral Fellowship

NIH Chemical Genomics Center (NCGC)
National Human Genome Research Institute (NHGRI)
National Institutes of Health (NIH)

Term: Two (2) years. Extendable from three (3) to five (5) years.

Charcot Marie Tooth Disease (CMT) is a heterogeneous group of genetic disorders that disupt the peripheral nervous system (PNS) of 1:2500 people of all backgrounds. CMT1A is the most frequent form, a demyelinating neuropathy caused by over-expression of the peripheral myelin protein 22 (PMP22) gene and its protein. The goals of the STAR initiative of the Charcot Marie Tooth Association (CMTA) are to identify medications that reduce PMP22 expression and treat patients with CMT1A. The NCGC is an ultrahighthroughput screening and chemistry center which discovers chemical probes of protein and cell functions, develops new paradigms to enable chemical genomics, and develops chemical starting points for new drugs for rare genetic and orphan diseases. Located 10 minutes north of the NIH Campus in Rockville, MD, the Center has a staff of over 60 biologists, chemists, engineers, and informatics scientists, who work with investigators throughout NIH and the world to translate the genome into biological function and therapeutics.

Job Description: The post-doctoral fellow will be responsible for development and performance of compound library screening efforts in Charcot- Marie-Tooth inherited peripheral neuropathy. Successful candidates should have experience with cell culture and reporter gene systems, an aptitude for instrumentation, and possess excellent analytical skills.

Responsibilities will include:
  • Interact with CMTA investigators to identify potential assays and methodologies that detect CMT phenotypes.
  • Develop and optimize cell-based and biochemical assays targeting CMT-based inherited peripheral neuropathy biology.
  • Work together with engineers to implement automated highthroughput screens on state-of-the art robotic systems.
  • Validate active compounds with secondary assays.
  • Interact with chemists and informatics scientists to aid molecular probe development.
  • Contribute to the writing of scientific manuscripts for publication, grants to support the CMTA screening program, and progress reports for the CMTA.

Contact: Applicants should send their CV including bibliography, and arrange for three letters of reference to be sent to James Inglese, Ph.D., Deputy Director, NIH Chemical Genomics Center, to ncgc@mail.nih.gov. Subject line should read: CMTA Post-Doc.

For more information on the NCGC, go to: NIH Chemical Genomics Center.

For more information on the NHGRI, go to www.genome.gov.

DHHS and NIH are Equal Opportunity Employers


Top of page

Posted: February 17, 2009




Print Version


See Also:

NIH Chemical Genomics Center

Dr. James Inglese



PrivacyCopyrightContactAccessibilitySite MapStaff DirectoryFOIAHome Department of Health and Human Services  National Institutes of Health  USA.gov